10-119425003-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005308.3(GRK5):c.451G>A(p.Glu151Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,611,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E151Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_005308.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRK5 | NM_005308.3 | c.451G>A | p.Glu151Lys | missense_variant | 6/16 | ENST00000392870.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRK5 | ENST00000392870.3 | c.451G>A | p.Glu151Lys | missense_variant | 6/16 | 1 | NM_005308.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152062Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251480Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135910
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1459180Hom.: 0 Cov.: 29 AF XY: 0.0000248 AC XY: 18AN XY: 726120
GnomAD4 genome AF: 0.000145 AC: 22AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.000202 AC XY: 15AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.451G>A (p.E151K) alteration is located in exon 6 (coding exon 6) of the GRK5 gene. This alteration results from a G to A substitution at nucleotide position 451, causing the glutamic acid (E) at amino acid position 151 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at